Search

Your search keyword '"Arumugam, Manimozhiyan"' showing total 466 results

Search Constraints

Start Over You searched for: Author "Arumugam, Manimozhiyan" Remove constraint Author: "Arumugam, Manimozhiyan"
466 results on '"Arumugam, Manimozhiyan"'

Search Results

1. Examining the healthy human microbiome concept

3. Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases

4. Oral supplementation of nicotinamide riboside alters intestinal microbial composition in rats and mice, but not humans

5. Reporting guidelines for human microbiome research: the STORMS checklist

6. Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial

7. Sphingolipids Are Depleted in Alcohol-Related Liver Fibrosis

9. OS-072-YI Identifying patterns of steatotic liver disease severity: a multiomic analysis of 834 distinct omics features from healthy to end-stage liver disease in 854 individuals

10. THU-055 Differential impact of proton pump inhibitors, statins, and nonselective beta-blockers on survival in different stages of chronic liver disease

11. OS-071-YI Variation of the human microbiome across multiple body sites and temporal dynamics in different stages of decompensated cirrhosis

13. Enterotypes in the landscape of gut microbial community composition.

14. Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associations

15. Review: Opportunities and barriers for omics-based biomarker discovery in steatotic liver diseases

16. Impact of acute alcohol consumption on circulating microbiome in asymptomatic alcohol-related liver disease

20. Trans-ethnic gut microbial signatures of prediabetic subjects from India and Denmark

21. Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India

22. Genomic diversity and ecology of human-associated Akkermansia species in the gut microbiome revealed by extensive metagenomic assembly

23. Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration

24. Clostridium scindens secretome suppresses virulence gene expression of Clostridioides difficile in a bile acid-independent manner

25. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2

26. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation

27. Recovery of gut microbiota of healthy adults following antibiotic exposure

30. Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial

34. Clostridium scindens secretome suppresses virulence gene expression of Clostridioides difficile in a bile acid-independent manner

35. Quantitative differences in synthetic gut microbial inoculums do not affect the final stabilized in vitro community compositions

36. Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits

37. Sphingolipids Are Depleted in Alcohol-Related Liver Fibrosis

38. Oral supplementation of nicotinamide riboside alters intestinal microbial composition in rats and mice, but not humans

39. Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models

41. Author Correction: Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation

42. Human gut microbes impact host serum metabolome and insulin sensitivity

43. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota

44. Anti-fibrotic effect of rifaximin in early alcohol-related liver disease: a double-blind, randomised, placebo-controlled trial

46. MIntO:A Modular and Scalable Pipeline For Microbiome Metagenomic and Metatranscriptomic Data Integration

47. The effect of gluten in adolescents and young adults with gastrointestinal symptoms:A blinded randomised cross-over trial

48. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer

49. Author Correction: Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2

Catalog

Books, media, physical & digital resources